US2016250030A1PendingUtilityA1
Negative-positive pressurizable implant
Est. expirySep 12, 2031(~5.2 yrs left)· nominal 20-yr term from priority
A61F 2002/2817A61F 2002/30884A61F 2/4003A61F 2/4014A61F 2002/3092A61F 2002/3068A61F 2002/30691A61F 2002/30332A61F 2250/0024A61F 2250/0069A61F 2002/30593A61F 2/28A61F 2250/0068A61F 2002/4025
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A pressurizable implant, comprising a body and at least one porous arm extending from and interconnected to the body, the at least one porous arm being configured to accommodate a pressure gradient that is created by a device removably connectable to the body.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . A method of distributing a pressure gradient across an implant, the method comprising:
providing an implant having a body, an internal chamber and at least one porous arm extending from and interconnected to the internal chamber via a channel or duct; placing an airtight seal in the internal chamber; connecting a device to the airtight seal; and actuating the device to create a pressure differential across at least a portion of the implant.
17 . The method of claim 16 , wherein connecting the device to the airtight seal comprises:
connecting a syringe to the airtight seal.
18 . The method of claim 17 , wherein creating the pressure differential comprises:
distributing a negative pressure gradient across the at least one porous arm by removing air through the airtight seal upon actuating the syringe.
19 . The method of claim 17 , wherein creating the pressure differential comprises:
distributing a positive pressure gradient across the at least one porous arm by delivering a pharmacological agent through the airtight seal upon actuating the syringe.
20 . The method of claim 16 , further comprising:
removing the airtight seal from the implant.
21 . The method of claim 19 , wherein the pharmacological agent includes at least one of medicines, antibiotics, growth factors and blood platelets.
22 . The method of claim 16 , wherein the airtight seal is a rubber stopper.
23 . The method of claim 16 , wherein the body is shaped as a cylinder and defines a longitudinal axis.
24 . The method of claim 23 , wherein the implant includes a plurality of porous arms interconnected to the body at a single location along the longitudinal axis.
25 . A method for distributing a negative pressure gradient across an implant, the method comprising:
providing an implant having a body, an internal chamber and at least one porous arm extending from and interconnected to the internal chamber via a channel or duct; placing a rubber stopper at least partially within the internal chamber; connecting a syringe to the rubber stopper; and pulling on a plunger of the syringe to remove air through the rubber stopper, thereby distributing a negative pressure gradient across the at least one porous arm.
26 . The method of claim 25 , further comprising:
removing the rubber stopper from the implant.
27 . The method of claim 25 , wherein the body is shaped as a cylinder and defines a longitudinal axis.
28 . The method of claim 27 , wherein the implant includes a plurality of porous arms interconnected to the body at a single location along the longitudinal axis.
29 . A method for distributing a positive pressure gradient across an implant, the method comprising:
providing an implant having a body, an internal chamber and at least one porous arm extending from and interconnected to the internal chamber via a channel or duct; placing a rubber stopper at least partially within the internal chamber; connecting a syringe to the rubber stopper; pushing on a plunger of the syringe to deliver a pharmacological agent through the rubber stopper, thereby distributing a positive pressure gradient across the at least one porous arm.
30 . The method of claim 29 , further comprising:
removing the rubber stopper from the implant.
31 . The method of claim 29 , wherein the pharmacological agent includes at least one of medicines, antibiotics, growth factors and blood platelets.
32 . The method of claim 29 , wherein the body is shaped as a cylinder and defines a longitudinal axis.
33 . The method of claim 32 , wherein the implant includes a plurality of porous arms interconnected to the body at a single location along the longitudinal axis.Join the waitlist — get patent alerts
Track US2016250030A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.